{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:06:04Z","timestamp":1792037164049,"version":"4.4.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Funda\u00e7\u00e3o de Apoio \u00e0 Pesquisa do Estado do Rio Grande do Sul (FAPERGS\/ Brazilian National Institute of Hormones and Women\u2019s Health\/Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","award":["FAPERGS INCT 17\/2551-0000519-8"],"award-info":[{"award-number":["FAPERGS INCT 17\/2551-0000519-8"]}]},{"name":"Brazilian National Institute of Hormones and Women\u2019s Health\/Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","award":["CNPq INCT 465482\/2014-7"],"award-info":[{"award-number":["CNPq INCT 465482\/2014-7"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-024-01550-w","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T08:43:39Z","timestamp":1732265019000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Gut microbiota and gut-derived metabolites are altered and associated with dietary intake in women with polycystic ovary syndrome"],"prefix":"10.1186","volume":"17","author":[{"given":"Tha\u00eds Rasia","family":"da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas Bandeira","family":"Marchesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pabulo Henrique","family":"Rampelotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisse","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago Franco","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikard","family":"Landberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"de Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6734-7688","authenticated-orcid":false,"given":"Poli Mara","family":"Spritzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,22]]},"reference":[{"key":"1550_CR1","doi-asserted-by":"publisher","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","volume":"2","author":"R Azziz","year":"2016","unstructured":"Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"1550_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","volume":"97","author":"BC Fauser","year":"2012","unstructured":"Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012;97(1):28\u2013e3825.","journal-title":"Fertil Steril"},{"key":"1550_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1741-7015-8-41","volume":"8","author":"H Teede","year":"2010","unstructured":"Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010;8:41.","journal-title":"BMC Med"},{"issue":"3","key":"1550_CR4","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.fertnstert.2018.11.034","volume":"111","author":"LB Marchesan","year":"2019","unstructured":"Marchesan LB, Spritzer PM. ACC\/AHA 2017 definition of high blood pressure: implications for women with polycystic ovary syndrome. Fertil Steril. 2019;111(3):579\u2013e871.","journal-title":"Fertil Steril"},{"key":"1550_CR5","doi-asserted-by":"crossref","unstructured":"Huang MC, Chen PL, Hsu CL. Transcriptome analysis of mesenchymal progenitor cells revealed Molecular insights into metabolic dysfunction and inflammation in polycystic ovary syndrome. Int J Mol Sci. 2024;25(14).","DOI":"10.3390\/ijms25147948"},{"issue":"5","key":"1550_CR6","doi-asserted-by":"publisher","first-page":"R219","DOI":"10.1530\/REP-14-0435","volume":"149","author":"PM Spritzer","year":"2015","unstructured":"Spritzer PM, Lecke SB, Satler F, Morsch DM. Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome. Reproduction. 2015;149(5):R219\u201327.","journal-title":"Reproduction"},{"issue":"3","key":"1550_CR7","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/humrep\/des463","volume":"28","author":"NK Stepto","year":"2013","unstructured":"Stepto NK, Cassar S, Joham AE, Hutchison SK, Harrison CL, Goldstein RF, et al. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Hum Reprod. 2013;28(3):777\u201384.","journal-title":"Hum Reprod"},{"issue":"34","key":"1550_CR8","doi-asserted-by":"publisher","first-page":"5569","DOI":"10.2174\/138161212803307590","volume":"18","author":"E Diamanti-Kandarakis","year":"2012","unstructured":"Diamanti-Kandarakis E, Spritzer PM, Sir-Petermann T, Motta AB. Insulin resistance and polycystic ovary syndrome through life. Curr Pharm Des. 2012;18(34):5569\u201376.","journal-title":"Curr Pharm Des"},{"key":"1550_CR9","doi-asserted-by":"publisher","first-page":"1402905","DOI":"10.3389\/fendo.2024.1402905","volume":"15","author":"N Veli\u010dkovi\u0107","year":"2024","unstructured":"Veli\u010dkovi\u0107 N, Mi\u0107i\u0107 B, Teofilovi\u0107 A, Milovanovic M, Jovanovi\u0107 M, Djordjevic A, et al. Overfeeding in the early postnatal period aggravates inflammation and hepatic insulin sensitivity in the 5\u03b1-dihydrotestosterone-induced animal model of PCOS. Front Endocrinol (Lausanne). 2024;15:1402905.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"1550_CR10","doi-asserted-by":"publisher","first-page":"G43","DOI":"10.1093\/ejendo\/lvad096","volume":"189","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Eur J Endocrinol. 2023;189(2):G43\u201364.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"1550_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12902-022-01208-y","volume":"23","author":"S Cowan","year":"2023","unstructured":"Cowan S, Lim S, Alycia C, Pirotta S, Thomson R, Gibson-Helm M, et al. Lifestyle management in polycystic ovary syndrome - beyond diet and physical activity. BMC Endocr Disord. 2023;23(1):14.","journal-title":"BMC Endocr Disord"},{"issue":"7","key":"1550_CR12","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1210\/jc.2014-2074","volume":"99","author":"G Tarantino","year":"2014","unstructured":"Tarantino G. Gut microbiome, obesity-related comorbidities, and low-grade chronic inflammation. J Clin Endocrinol Metab. 2014;99(7):2343\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"1550_CR13","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.3389\/fmicb.2018.01835","volume":"9","author":"ZY Kho","year":"2018","unstructured":"Kho ZY, Lal SK. The human gut microbiome - A potential Controller of Wellness and Disease. Front Microbiol. 2018;9:1835.","journal-title":"Front Microbiol"},{"issue":"1","key":"1550_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1017\/S0954422410000041","volume":"23","author":"A Fardet","year":"2010","unstructured":"Fardet A. New hypotheses for the health-protective mechanisms of whole-grain cereals: what is beyond fibre? Nutr Res Rev. 2010;23(1):65\u2013134.","journal-title":"Nutr Res Rev"},{"key":"1550_CR15","doi-asserted-by":"crossref","unstructured":"Palmn\u00e4s-B\u00e9dard MSA, Costabile G, Vetrani C, \u00c5berg S, Hjalmarsson Y, Dicksved J et al. The human gut microbiota and glucose metabolism: a scoping review of key Bacteria and the potential role of short chain fatty acids. Am J Clin Nutr. 2022.","DOI":"10.1093\/ajcn\/nqac217"},{"key":"1550_CR16","doi-asserted-by":"crossref","unstructured":"Rosli NSA, Abd Gani S, Khayat ME, Zaidan UH, Ismail A, Abdul Rahim MBH. Short-chain fatty acids: possible regulators of insulin secretion. Mol Cell Biochem. 2022.","DOI":"10.1007\/s11010-022-04528-8"},{"issue":"7480","key":"1550_CR17","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature12721","volume":"504","author":"Y Furusawa","year":"2013","unstructured":"Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013;504(7480):446\u201350.","journal-title":"Nature"},{"key":"1550_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3389\/fimmu.2020.00557","volume":"11","author":"S Cussotto","year":"2020","unstructured":"Cussotto S, Delgado I, Anesi A, Dexpert S, Aubert A, Beau C, et al. Tryptophan metabolic pathways are altered in obesity and are Associated with systemic inflammation. Front Immunol. 2020;11:557.","journal-title":"Front Immunol"},{"key":"1550_CR19","doi-asserted-by":"crossref","unstructured":"Sehgal R, Ilha M, Vaittinen M, Kaminska D, M\u00e4nnist\u00f6 V, K\u00e4rj\u00e4 V et al. Indole-3-Propionic Acid, a gut-derived Tryptophan Metabolite, associates with hepatic fibrosis. Nutrients. 2021;13(10).","DOI":"10.3390\/nu13103509"},{"key":"1550_CR20","doi-asserted-by":"publisher","first-page":"46337","DOI":"10.1038\/srep46337","volume":"7","author":"VD de Mello","year":"2017","unstructured":"de Mello VD, Paananen J, Lindstr\u00f6m J, Lankinen MA, Shi L, Kuusisto J, et al. Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish diabetes Prevention Study. Sci Rep. 2017;7:46337.","journal-title":"Sci Rep"},{"issue":"5","key":"1550_CR21","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1161\/CIRCRESAHA.122.321253","volume":"131","author":"H Xue","year":"2022","unstructured":"Xue H, Chen X, Yu C, Deng Y, Zhang Y, Chen S, et al. Gut Microbially Produced Indole-3-Propionic Acid inhibits atherosclerosis by Promoting Reverse Cholesterol Transport and its Deficiency is causally related to atherosclerotic Cardiovascular Disease. Circ Res. 2022;131(5):404\u201320.","journal-title":"Circ Res"},{"issue":"6","key":"1550_CR22","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1136\/gutjnl-2020-323071","volume":"70","author":"A Agus","year":"2021","unstructured":"Agus A, Cl\u00e9ment K, Sokol H. Gut microbiota-derived metabolites as central regulators in metabolic disorders. Gut. 2021;70(6):1174\u201382.","journal-title":"Gut"},{"issue":"2","key":"1550_CR23","doi-asserted-by":"publisher","first-page":"bvaa177","DOI":"10.1210\/jendso\/bvaa177","volume":"5","author":"MG Rizk","year":"2021","unstructured":"Rizk MG, Thackray VG. Intersection of polycystic ovary syndrome and the gut Microbiome. J Endocr Soc. 2021;5(2):bvaa177.","journal-title":"J Endocr Soc"},{"issue":"1","key":"1550_CR24","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.mehy.2012.04.016","volume":"79","author":"K Tremellen","year":"2012","unstructured":"Tremellen K, Pearce K. Dysbiosis of gut microbiota (DOGMA)--a novel theory for the development of polycystic ovarian syndrome. Med Hypotheses. 2012;79(1):104\u201312.","journal-title":"Med Hypotheses"},{"key":"1550_CR25","doi-asserted-by":"crossref","unstructured":"Al Bander Z, Nitert MD, Mousa A, Naderpoor N. The gut microbiota and inflammation: an overview. Int J Environ Res Public Health. 2020;17(20).","DOI":"10.3390\/ijerph17207618"},{"issue":"4","key":"1550_CR26","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.fertnstert.2013.06.005","volume":"100","author":"SK Graff","year":"2013","unstructured":"Graff SK, M\u00e1rio FM, Alves BC, Spritzer PM. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes. Fertil Steril. 2013;100(4):1081\u20138.","journal-title":"Fertil Steril"},{"issue":"1","key":"1550_CR27","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.fertnstert.2012.08.049","volume":"99","author":"K Di Domenico","year":"2013","unstructured":"Di Domenico K, Wiltgen D, Nickel FJ, Magalh\u00e3es JA, Moraes RS, Spritzer PM. Cardiac autonomic modulation in polycystic ovary syndrome: does the phenotype matter? Fertil Steril. 2013;99(1):286\u201392.","journal-title":"Fertil Steril"},{"issue":"1","key":"1550_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"REA-SPCW Group","year":"2004","unstructured":"Group REA-SPCW. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19\u201325.","journal-title":"Fertil Steril"},{"issue":"9","key":"1550_CR29","doi-asserted-by":"publisher","first-page":"e035677","DOI":"10.1136\/bmjopen-2019-035677","volume":"10","author":"KT Elvers","year":"2020","unstructured":"Elvers KT, Wilson VJ, Hammond A, Duncan L, Huntley AL, Hay AD, et al. Antibiotic-induced changes in the human gut microbiota for the most commonly prescribed antibiotics in primary care in the UK: a systematic review. BMJ Open. 2020;10(9):e035677.","journal-title":"BMJ Open"},{"issue":"4","key":"1550_CR30","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1590\/S0102-311X2009000400015","volume":"25","author":"AF Zanolla","year":"2009","unstructured":"Zanolla AF, Olinto MT, Henn RL, Wahrlich V, Anjos LA. [Assessment of reproducibility and validity of a food frequency questionnaire in a sample of adults living in Porto Alegre, Rio Grande do Sul State, Brazil]. Cad Saude Publica. 2009;25(4):840\u20138.","journal-title":"Cad Saude Publica"},{"key":"1550_CR31","unstructured":"Tabela Brasileira de Composi\u00e7\u00e3o de Alimentos (TBCA): Universidade de S\u00e3o Paulo (USP). Food Research Center (FoRC). S\u00e3o Paulo. 2017 [ Vers\u00e3o 6.0.:[ http:\/\/www.fcf.usp.br\/tbca"},{"key":"1550_CR32","first-page":"1","volume":"66","author":"Carbohydrates in human nutrition","year":"1998","unstructured":"Carbohydrates in human nutrition. Report of a Joint FAO\/WHO Expert Consultation. FAO Food Nutr Pap. 1998;66:1\u2013140.","journal-title":"FAO Food Nutr Pap"},{"issue":"1","key":"1550_CR33","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1139\/h11-145","volume":"37","author":"SK Graff","year":"2012","unstructured":"Graff SK, Alves BC, Toscani MK, Spritzer PM. Benefits of pedometer-measured habitual physical activity in healthy women. Appl Physiol Nutr Metab. 2012;37(1):149\u201356.","journal-title":"Appl Physiol Nutr Metab"},{"issue":"7","key":"1550_CR34","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412\u20139.","journal-title":"Diabetologia"},{"issue":"6","key":"1550_CR35","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s10096-019-03520-3","volume":"38","author":"SA Boers","year":"2019","unstructured":"Boers SA, Jansen R, Hays JP. Understanding and overcoming the pitfalls and biases of next-generation sequencing (NGS) methods for use in the routine clinical microbiological diagnostic laboratory. Eur J Clin Microbiol Infect Dis. 2019;38(6):1059\u201370.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"1550_CR36","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1128\/JCM.01228-07","volume":"45","author":"JM Janda","year":"2007","unstructured":"Janda JM, Abbott SL. 16S rRNA gene sequencing for bacterial identification in the diagnostic laboratory: pluses, perils, and pitfalls. J Clin Microbiol. 2007;45(9):2761\u20134.","journal-title":"J Clin Microbiol"},{"issue":"23","key":"1550_CR37","doi-asserted-by":"publisher","first-page":"7537","DOI":"10.1128\/AEM.01541-09","volume":"75","author":"PD Schloss","year":"2009","unstructured":"Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol. 2009;75(23):7537\u201341.","journal-title":"Appl Environ Microbiol"},{"key":"1550_CR38","doi-asserted-by":"publisher","first-page":"e2584","DOI":"10.7717\/peerj.2584","volume":"4","author":"T Rognes","year":"2016","unstructured":"Rognes T, Flouri T, Nichols B, Quince C, Mah\u00e9 F. VSEARCH: a versatile open source tool for metagenomics. PeerJ. 2016;4:e2584.","journal-title":"PeerJ"},{"issue":"1","key":"1550_CR39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41387-018-0046-9","volume":"8","author":"M Tuomainen","year":"2018","unstructured":"Tuomainen M, Lindstr\u00f6m J, Lehtonen M, Auriola S, Pihlajam\u00e4ki J, Peltonen M, et al. Associations of serum indolepropionic acid, a gut microbiota metabolite, with type 2 diabetes and low-grade inflammation in high-risk individuals. Nutr Diabetes. 2018;8(1):35.","journal-title":"Nutr Diabetes"},{"key":"1550_CR40","doi-asserted-by":"crossref","unstructured":"Iversen KN, Dicksved J, Zoki C, Fristedt R, Pelve EA, Langton M et al. The effects of High Fiber Rye, compared to Refined Wheat, on Gut Microbiota Composition, plasma short chain fatty acids, and implications for weight loss and metabolic risk factors (the RyeWeight Study). Nutrients. 2022;14(8).","DOI":"10.3390\/nu14081669"},{"key":"1550_CR41","doi-asserted-by":"crossref","unstructured":"Zhang J, Sun Z, Jiang S, Bai X, Ma C, Peng Q et al. Probiotic Bifidobacterium lactis V9 regulates the secretion of sex hormones in polycystic ovary syndrome patients through the gut-brain Axis. mSystems. 2019;4(2).","DOI":"10.1128\/mSystems.00017-19"},{"issue":"6","key":"1550_CR42","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12(6):R60.","journal-title":"Genome Biol"},{"issue":"6","key":"1550_CR43","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41587-020-0548-6","volume":"38","author":"GM Douglas","year":"2020","unstructured":"Douglas GM, Maffei VJ, Zaneveld JR, Yurgel SN, Brown JR, Taylor CM, et al. PICRUSt2 for prediction of metagenome functions. Nat Biotechnol. 2020;38(6):685\u20138.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"1550_CR44","doi-asserted-by":"publisher","first-page":"2085961","DOI":"10.1080\/19490976.2022.2085961","volume":"14","author":"V Rodriguez Paris","year":"2022","unstructured":"Rodriguez Paris V, Wong XYD, Solon-Biet SM, Edwards MC, Aflatounian A, Gilchrist RB, et al. The interplay between PCOS pathology and diet on gut microbiota in a mouse model. Gut Microbes. 2022;14(1):2085961.","journal-title":"Gut Microbes"},{"issue":"7","key":"1550_CR45","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1007\/s43032-022-01131-6","volume":"30","author":"L Fu","year":"2023","unstructured":"Fu L, Li Y, Bian Y, Wang Q, Li J, Wang Y, et al. The nutritional intervention improves the Metabolic Profile of overweight and obese PCOS along with the differences in gut microbiota. Reprod Sci. 2023;30(7):2210\u20138.","journal-title":"Reprod Sci"},{"issue":"3","key":"1550_CR46","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1210\/clinem\/dgaa848","volume":"106","author":"K L\u00fcll","year":"2021","unstructured":"L\u00fcll K, Arffman RK, Sola-Leyva A, Molina NM, Aasmets O, Herzig KH, et al. The gut Microbiome in Polycystic Ovary Syndrome and its Association with metabolic traits. J Clin Endocrinol Metab. 2021;106(3):858\u201371.","journal-title":"J Clin Endocrinol Metab"},{"key":"1550_CR47","doi-asserted-by":"crossref","unstructured":"Yang YL, Zhou WW, Wu S, Tang WL, Wang ZW, Zhou ZY et al. Intestinal Flora is a key factor in insulin resistance and contributes to the development of polycystic ovary syndrome. Endocrinology. 2021;162(10).","DOI":"10.1210\/endocr\/bqab118"},{"issue":"7","key":"1550_CR48","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1210\/jc.2017-02799","volume":"103","author":"M Insenser","year":"2018","unstructured":"Insenser M, Murri M, Del Campo R, Mart\u00ednez-Garc\u00eda M, Fern\u00e1ndez-Dur\u00e1n E, Escobar-Morreale HF. Gut microbiota and the polycystic ovary syndrome: influence of sex, sex hormones, and obesity. J Clin Endocrinol Metab. 2018;103(7):2552\u201362.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1550_CR49","doi-asserted-by":"publisher","first-page":"e0168390","DOI":"10.1371\/journal.pone.0168390","volume":"12","author":"L Lindheim","year":"2017","unstructured":"Lindheim L, Bashir M, M\u00fcnzker J, Trummer C, Zachhuber V, Leber B, et al. Alterations in gut microbiome composition and Barrier Function Are Associated with Reproductive and metabolic defects in women with polycystic ovary syndrome (PCOS): a pilot study. PLoS ONE. 2017;12(1):e0168390.","journal-title":"PLoS ONE"},{"key":"1550_CR50","doi-asserted-by":"publisher","first-page":"108717","DOI":"10.1016\/j.intimp.2022.108717","volume":"107","author":"J Huang","year":"2022","unstructured":"Huang J, Chen P, Xiang Y, Liang Q, Wu T, Liu J, et al. Gut microbiota dysbiosis-derived macrophage pyroptosis causes polycystic ovary syndrome via steroidogenesis disturbance and apoptosis of granulosa cells. Int Immunopharmacol. 2022;107:108717.","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"1550_CR51","doi-asserted-by":"publisher","first-page":"e21971","DOI":"10.1096\/fj.202101051R","volume":"35","author":"A Kusamoto","year":"2021","unstructured":"Kusamoto A, Harada M, Azhary JMK, Kunitomi C, Nose E, Koike H, et al. Temporal relationship between alterations in the gut microbiome and the development of polycystic ovary syndrome-like phenotypes in prenatally androgenized female mice. FASEB J. 2021;35(11):e21971.","journal-title":"FASEB J"},{"key":"1550_CR52","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3389\/fendo.2020.00628","volume":"11","author":"L Zhou","year":"2020","unstructured":"Zhou L, Ni Z, Yu J, Cheng W, Cai Z, Yu C. Correlation between fecal metabolomics and gut microbiota in obesity and polycystic ovary syndrome. Front Endocrinol (Lausanne). 2020;11:628.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1550_CR53","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41522-022-00273-4","volume":"8","author":"YY Cai","year":"2022","unstructured":"Cai YY, Huang FQ, Lao X, Lu Y, Gao X, Alolga RN, et al. Integrated metagenomics identifies a crucial role for trimethylamine-producing Lachnoclostridium in promoting atherosclerosis. NPJ Biofilms Microbiomes. 2022;8(1):11.","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"7","key":"1550_CR54","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.tcm.2019.09.004","volume":"30","author":"M Cree-Green","year":"2020","unstructured":"Cree-Green M. Editoral commentary: understanding cardiovascular disease risk in women with polycystic ovary syndrome. Trends Cardiovasc Med. 2020;30(7):405\u20136.","journal-title":"Trends Cardiovasc Med"},{"issue":"5","key":"1550_CR55","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.fertnstert.2022.02.028","volume":"117","author":"JMD Gomez","year":"2022","unstructured":"Gomez JMD, VanHise K, Stachenfeld N, Chan JL, Merz NB, Shufelt C. Subclinical cardiovascular disease and polycystic ovary syndrome. Fertil Steril. 2022;117(5):912\u201323.","journal-title":"Fertil Steril"},{"issue":"4","key":"1550_CR56","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1007\/s00125-018-4550-1","volume":"61","author":"KH Allin","year":"2018","unstructured":"Allin KH, Tremaroli V, Caesar R, Jensen BAH, Damgaard MTF, Bahl MI, et al. Aberrant intestinal microbiota in individuals with prediabetes. Diabetologia. 2018;61(4):810\u201320.","journal-title":"Diabetologia"},{"key":"1550_CR57","doi-asserted-by":"crossref","unstructured":"Li H, Liu B, Song J, An Z, Zeng X, Li J et al. Characteristics of gut microbiota in patients with hypertension and\/or hyperlipidemia: a cross-sectional study on rural residents in Xinxiang County, Henan Province. Microorganisms. 2019;7(10).","DOI":"10.3390\/microorganisms7100399"},{"issue":"7","key":"1550_CR58","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1159\/000524282","volume":"47","author":"Y Qin","year":"2022","unstructured":"Qin Y, Zhao J, Wang Y, Bai M, Sun S. Specific alterations of gut microbiota in Chinese patients with hypertension: a systematic review and Meta-analysis. Kidney Blood Press Res. 2022;47(7):433\u201347.","journal-title":"Kidney Blood Press Res"},{"key":"1550_CR59","doi-asserted-by":"crossref","unstructured":"Ozkul G, Yilmaz Isikhan C, Acikgoz S, Yildiz A. BO. Characterization of gut microbiota in polycystic ovary syndrome: findings from a lean population. Eur J Clin Invest. 2021;51(4).","DOI":"10.1111\/eci.13417"},{"key":"1550_CR60","doi-asserted-by":"publisher","first-page":"1275419","DOI":"10.3389\/fendo.2024.1275419","volume":"15","author":"J Wang","year":"2024","unstructured":"Wang J, Fiori PL, Capobianco G, Carru C, Chen Z. Gut microbiota and polycystic ovary syndrome, focus on genetic associations: a bidirectional mendelian randomization study. Front Endocrinol (Lausanne). 2024;15:1275419.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"1550_CR61","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1080\/19490976.2019.1586038","volume":"10","author":"C Menni","year":"2019","unstructured":"Menni C, Hernandez MM, Vital M, Mohney RP, Spector TD, Valdes AM. Circulating levels of the anti-oxidant indoleproprionic acid are associated with higher gut microbiome diversity. Gut Microbes. 2019;10(6):688\u201395.","journal-title":"Gut Microbes"},{"issue":"3","key":"1550_CR62","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s002489900020","volume":"33","author":"EA Smith","year":"1997","unstructured":"Smith EA, Macfarlane GT. Formation of Phenolic and Indolic compounds by anaerobic Bacteria in the human large intestine. Microb Ecol. 1997;33(3):180\u20138.","journal-title":"Microb Ecol"},{"issue":"3","key":"1550_CR63","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1365-2672.1996.tb04331.x","volume":"81","author":"EA Smith","year":"1996","unstructured":"Smith EA, Macfarlane GT. Enumeration of human colonic bacteria producing phenolic and indolic compounds: effects of pH, carbohydrate availability and retention time on dissimilatory aromatic amino acid metabolism. J Appl Bacteriol. 1996;81(3):288\u2013302.","journal-title":"J Appl Bacteriol"},{"key":"1550_CR64","doi-asserted-by":"crossref","unstructured":"Sehgal R, de Mello VD, M\u00e4nnist\u00f6 V, Lindstr\u00f6m J, Tuomilehto J, Pihlajam\u00e4ki J et al. Indolepropionic Acid, a gut Bacteria-produced Tryptophan Metabolite and the risk of type 2 diabetes and non-alcoholic fatty liver disease. Nutrients. 2022;14(21).","DOI":"10.3390\/nu14214695"},{"issue":"2","key":"1550_CR65","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.cell.2018.08.040","volume":"175","author":"X Liu","year":"2018","unstructured":"Liu X, Cooper DE, Cluntun AA, Warmoes MO, Zhao S, Reid MA, et al. Acetate production from glucose and coupling to mitochondrial metabolism in mammals. Cell. 2018;175(2):502\u2013e1313.","journal-title":"Cell"},{"key":"1550_CR66","doi-asserted-by":"crossref","unstructured":"Sowah SA, Hirche F, Milanese A, Johnson TS, Grafetst\u00e4tter M, Sch\u00fcbel R et al. Changes in plasma short-chain fatty acid levels after Dietary Weight loss among overweight and obese adults over 50 weeks. Nutrients. 2020;12(2).","DOI":"10.3390\/nu12020452"},{"issue":"46","key":"1550_CR67","doi-asserted-by":"publisher","first-page":"80472","DOI":"10.18632\/oncotarget.19058","volume":"8","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Liu L, Yin TL, Yang J, Xiong CL. Follicular metabolic changes and effects on oocyte quality in polycystic ovary syndrome patients. Oncotarget. 2017;8(46):80472\u201380.","journal-title":"Oncotarget"},{"issue":"1","key":"1550_CR68","doi-asserted-by":"publisher","first-page":"2240050","DOI":"10.1080\/19490976.2023.2240050","volume":"15","author":"A Nogal","year":"2023","unstructured":"Nogal A, Asnicar F, Vijay A, Kouraki A, Visconti A, Louca P, et al. Genetic and gut microbiome determinants of SCFA circulating and fecal levels, postprandial responses and links to chronic and acute inflammation. Gut Microbes. 2023;15(1):2240050.","journal-title":"Gut Microbes"},{"issue":"1","key":"1550_CR69","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ajcnut.2023.10.025","volume":"119","author":"MTB Madsen","year":"2024","unstructured":"Madsen MTB, Landberg R, Nielsen DS, Zhang Y, Anneberg OMR, Lauritzen L, et al. Effects of Wholegrain compared to Refined Grain Intake on cardiometabolic risk markers, gut microbiota, and gastrointestinal symptoms in children: a randomized crossover trial. Am J Clin Nutr. 2024;119(1):18\u201328.","journal-title":"Am J Clin Nutr"},{"issue":"3\u20134","key":"1550_CR70","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1159\/000484325","volume":"71","author":"SK Graff","year":"2017","unstructured":"Graff SK, Mario FM, Magalh\u00e3es JA, Moraes RS, Spritzer PM. Saturated Fat Intake is related to heart rate variability in women with polycystic ovary syndrome. Ann Nutr Metab. 2017;71(3\u20134):224\u201333.","journal-title":"Ann Nutr Metab"},{"key":"1550_CR71","doi-asserted-by":"publisher","first-page":"911992","DOI":"10.3389\/fmicb.2022.911992","volume":"13","author":"G Li","year":"2022","unstructured":"Li G, Liu Z, Ren F, Shi H, Zhao Q, Song Y, et al. Alterations of gut microbiome and fecal fatty acids in patients with polycystic ovary syndrome in Central China. Front Microbiol. 2022;13:911992.","journal-title":"Front Microbiol"},{"issue":"12","key":"1550_CR72","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1038\/ijo.2014.46","volume":"38","author":"S Rahat-Rozenbloom","year":"2014","unstructured":"Rahat-Rozenbloom S, Fernandes J, Gloor GB, Wolever TM. Evidence for greater production of colonic short-chain fatty acids in overweight than lean humans. Int J Obes (Lond). 2014;38(12):1525\u201331.","journal-title":"Int J Obes (Lond)"},{"key":"1550_CR73","doi-asserted-by":"crossref","unstructured":"de la Cuesta-Zuluaga J, Mueller NT, \u00c1lvarez-Quintero R, Vel\u00e1squez-Mej\u00eda EP, Sierra JA, Corrales-Agudelo V et al. Higher Fecal Short-Chain Fatty Acid Levels Are Associated with Gut Microbiome Dysbiosis, Obesity, Hypertension and Cardiometabolic Disease Risk Factors. Nutrients. 2018;11(1).","DOI":"10.3390\/nu11010051"},{"issue":"1","key":"1550_CR74","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/oby.2009.167","volume":"18","author":"A Schwiertz","year":"2010","unstructured":"Schwiertz A, Taras D, Sch\u00e4fer K, Beijer S, Bos NA, Donus C, et al. Microbiota and SCFA in lean and overweight healthy subjects. Obes (Silver Spring). 2010;18(1):190\u20135.","journal-title":"Obes (Silver Spring)"},{"issue":"7122","key":"1550_CR75","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/nature05414","volume":"444","author":"PJ Turnbaugh","year":"2006","unstructured":"Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027\u201331.","journal-title":"Nature"},{"issue":"7695","key":"1550_CR76","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nature25973","volume":"555","author":"D Rothschild","year":"2018","unstructured":"Rothschild D, Weissbrod O, Barkan E, Kurilshikov A, Korem T, Zeevi D, et al. Environment dominates over host genetics in shaping human gut microbiota. Nature. 2018;555(7695):210\u20135.","journal-title":"Nature"},{"issue":"1","key":"1550_CR77","doi-asserted-by":"publisher","first-page":"e0168390","DOI":"10.1371\/journal.pone.0168390","volume":"12","author":"L Lindheim","year":"2017","unstructured":"Lindheim L, Bashir M, Munzker J, Trummer C, Zachhuber V, Leber B, et al. Alterations in gut microbiome composition and Barrier Function Are Associated with Reproductive and metabolic defects in women with polycystic ovary syndrome (PCOS): a pilot study. PLoS ONE. 2017;12(1):e0168390.","journal-title":"PLoS ONE"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-024-01550-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-024-01550-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-024-01550-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T10:07:46Z","timestamp":1732270066000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-024-01550-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1550"],"URL":"https:\/\/doi.org\/10.1186\/s13048-024-01550-w","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,22]]},"assertion":[{"value":"27 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Consent forms are available from the corresponding author on request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Each study participant provided written informed consent before enrollment. The study was approved by the HCPA Ethics Committee (CAAE 35025414.1.0000.5327) and conducted in accordance with the Helsinki Declaration.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Ethics and Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"232"}}